7,597.11

+17.04

+0.22%

52,250.75

+480.44

+0.93%

25,452.93

+15.93

+0.06%

2,828.08

+16.24

+0.58%

4.8820

-0.0470

-0.95%

19.69

+0.27

+1.39%

3,969.20

+70.30

+1.80%

76,818.03

-945.53

-1.22%

Crude Oil Dec 26

96.12

-8.00

-7.68%

US Private Equity

10,850.63

-82.20

-0.75%

Paris - Delayed Quote EUR

GenSight Biologics S.A. (SIGHT.PA)

0.0731 -0.0041 (-5.31%)

At close: 5:35:26 PM GMT+1

 All 
 News 
 Earnings Calls 
 Press Releases 
 SEC Filings 

GenSight Biologics Announces the Closing of its €1.0 Million Fundraising Supported by Existing Shareholders

Business Wire 17d ago

SIGHT.PA
-5.31%
Gensight Biologics and the 15-20 National Hospital Announce NEJM Publication on GS030 Phase 1/2 Trial Results in Late-Stage Retinitis Pigmentosa

Business Wire 25d ago

SIGHT.PA
-5.31%
GenSight Biologics Announces a Successful €1.0 Million Fundraising Supported by Existing Shareholders

Business Wire 25d ago

SIGHT.PA
-5.31%
GenSight Biologics Reports Cash Position as of September 30, 2026

Business Wire 25d ago

SIGHT.PA
-5.31%
GenSight Biologics Reports Interim Financial Results for the First Half of 2026 and Provides Business Updates

Business Wire 1mo ago

SIGHT.PA
-5.31%
GenSight Biologics Provides September 2026 Business Updates

Business Wire 1mo ago

SIGHT.PA
-5.31%
GenSight Biologics Reports Cash Position as of June 30, 2026, and Provides Business Updates

Business Wire 3mo ago

SIGHT.PA
-5.31%

Performance Overview

Return	SIGHT.PA	CAC 40 (^FCHI)
YTD	-29.98%	-1.25%
1-Year	-47.56%	-0.90%
3-Year	-83.06%	+13.98%

Mobilize your Website

View Site in Mobile | Classic

Share by: